Randomized trial: Gabapentin not effective for chronic pelvic pain in women

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial – The Lancet

Commentary: Common pelvic pain drug is ineffective, study finds – University of Edinburgh

Commentary on Twitter

1/5 Pleased to announce publication of our @GaPP2_trial in @lancet today – the largest ever study into treatment for female chronic pelvic pain @exppect @MRC_CRH @EdinUniMedicine @EdinUniMedia @NIHRresearch @BhamCTU @GynaeResearcher https://t.co/NYEAxo2VAh https://t.co/A0ZOr8gqc3 pic.twitter.com/zwn8F7KRHO

— Andrew Horne (@horne_research) September 25, 2020